Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Ovzon signs strategic agreement with Hellas-sat, expanding geographic reach

Ovzon and Hellas-sat have entered a strategic partnership to jointly offer high-capacity portable broadband solutions. The partnership leverages both companies’ technologies, industry expertise, resources, and market presence to promote joint business. Hellas-sat provides satellite capacity to power the services in Europe and the Middle East, while Ovzon will package and market the solutions. The agreement is complementary to Ovzon’s present agreements with Hispasat and Intelsat, bringing additional regional capacity in Europe.The service is based on Ovzon’s mobile, easy-to-use, terminals

First Results from WHO Solidarity Trial

WHO concludes that subcutaneous IFN beta-1a is ineffective in hospitalized COVID-19 patientsFaron Pharmaceuticals Oy(“Faron” or the “Company”) Company announcement, 16 October 2020 at 1.35 PM (EEST)  TURKU, FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company, today announces that the first results from the World Health Organization’s (WHO)  Solidarity trial have been made available as a preprint at medRxiv[1] while under review for publication in a medical journal. The results show that subcutaneous interferon (IFN) beta-

DBP International AB: the SI-053 efficacy was successfully proven in in vivo study in mice

Double Bond Pharmaceutical International AB (publ) (“DBP”, “Double Bond” or “Double Bond Pharmaceutical”) reports today that the in vivo proof-of-concept study of SI-053 was successfully finished.  The in vivo study of the efficacy of SI-053, Double Bond’s front-line product for local treatment of primary malignancies in the brain, was designed and set up in accordance with recommendations from the European Agency of Medicines (EMA). It consisted of using an immunodeficient nude mouse with an injection of human glioblastoma cells to mimic the brain tumor in a subcutaneous model. The

New date for publication of third quarter result

BEWiSynbra Group AB (publ) today announces a new date for the publication of the results for the third quarter of 2020: The results will be announced on Wednesday 11 November 2020 (previous date was set to 17 November). From the third quarter, the company will change its reporting currency from Swedish kroner (SEK) to Euro (EUR). The reason for the change is that a majority of the company’s revenues and costs incur in Euro. For further information, please contact: Marie Danielsson, CFO BEWi, tel: +46 70 661 0047Hanna Laurentz, Director of Communication and IR, BEWi ASA, tel: +46

Statement of the Board of Directors of Ahlstrom-Munksjö Oyj Regarding the Voluntary Public Cash Tender Offer by Spa Holdings 3 Oy

AHLSTROM-MUNKSJÖ OYJ STOCK EXCHANGE RELEASE October 16, 2020 at 13:00 EEST NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. On September 24, 2020, Spa Holdings 3 Oy (the “Offeror”) announced that it will make a voluntary public cash tender offer to acquire all of the issued and outstanding shares in Ahlstrom-Munksjö Oyj (“Ahlstrom‑Munksjö”) that are not held by Ahlstrom-

Winner of Lindab’s Innovation Prize 2020

Båstad Makerspace is awarded this year’s innovation prize Lindab's newly established Innovation Prize is awarded to a company, individual or organization with a connection to the Båstad region, that can demonstrate an innovative and sustainable product or service, with commercial and/or socio-economic potential that can be put into practice. This year's winner is Båstad Makerspace. Båstad Makerspace is a creative workshop, aimed at children and young people, that encourages creativity, problem solving and technology development. Båstad Makerspace is run on a non-profit basis and

Interim Report Third Quarter 2020

Third quarter 2020 Continuing operations · Order intake 19,909 million SEK · Revenues 20,145 million SEK · Operating profit 3,459 million SEK · Operating margin 17.2% · Adjusted operating profit 3,493 million SEK · Adjusted operating margin 17.3% · Profit after financial items 3,988 million SEK · Adjusted profit after financial items 3,436 million SEK · Earnings per share 2.54 SEK · Adjusted earnings per share 2.09 SEK · Cash flow from operations 4,845 million SEK Discontinued operations · Order intake 0 million SEK · Revenues 0 million SEK

Sandvik establishes new business area – Sandvik Rock Processing Solutions

Sandvik has decided to establish a new business area, Sandvik Rock Processing Solutions (SRP), as of 1 January 2021. The new business area will consist of the current Crushing and Screening division, which today is part of the Sandvik Mining and Rock Technology business area. The reason for this structural change is to further accelerate profitable growth within rock processing, based on Crushing and Screening addressing separate parts of the value chain and facing different competition to the other Sandvik Mining and Rock Technology divisions. “Sandvik is market leading within rock

Sandvik proceeds towards separate listing of Sandvik Materials Technology

Sandvik Board of Directors has today decided that following the completion of the internal separation of Sandvik Materials Technology (SMT), Sandvik will proceed with the preparation to distribute SMT to Sandvik’s shareholders and list the company’s shares on the Nasdaq Stockholm Exchange. The Board intends to propose the distribution and listing of the SMT shares at a shareholders’ meeting in 2022, provided that the circumstances are deemed right at the time. The intended distribution of shares is expected to meet the Lex Asea requirements and is subject to approval by Sandvik’s

Newsletter October 2020

Dear friends and colleagues!I hope you are all safe and healthy!We’re still in the middle of the Covid-19 crisis and even though life in some respects seems to be slowly returning to normal, there’s still a big uncertainty in other areas. We had plans to meet for an Odette International TC (TG) meeting in London on September 17-18 but due to uncertainty on safety and quarantine regulations, also this meeting had to be digitalized. However, good meeting with interesting topics and many steps forward for current and coming projects. Brief report to be found below.  In Odette Sweden, we also

Proposal from the Nomination Committee

Reference is made to the stock exchange notice dated September 29[th] including the invitation to the extraordinary general meeting. The proposal by the nomination committee for the extraordinary general meeting to be held on October 20[th], 2020 at 09:30 (CET), is now available at the company's website and attached to this message. Skudeneshavn, October 16[th], 2020. Solstad Offshore ASAwww.solstad.com This information is subject of the disclosure requirements according to the Norwegian Securities Trading Act section § 5-12.

SKF to publish nine-months results on 27 October

Gothenburg, 16 October 2020: SKF will publish its nine-months results for 2020 on 27 October 2020 at approximately 13:00 (CET). Investors, analysts and media are invited to join a Webcast, which will be held in English, at 14:00 (CET). Participants will have the opportunity to ask questions through a chat function. To join the Webcast, which will be held as a Microsoft Teams live event, please login at least 10 minutes before the start using the following link: https://bit.ly/353iirx. The link to the Webcast will also be available at https://investors.skf.com. All information

Approval of Folsyra EQL Pharma

The pharmaceutical Folsyra EQL Pharma, tablet 1 mg, has been approved for sale in Sweden by the Medical Products Agency.Folsyra EQL Pharma is a prescription drug used to treat folate deficiency or an increased folate need at, for example, gluten intolerance or during pregnancy. Folsyra EQL Pharma contains folic acid, a substance which in the body is converted into folate (vitamin B9), a vitamin that is naturally obtained through the diet, mainly from vegetables and bread. The market for prescription folic acid 1 mg is approximately SEK 23 million in total annual sales in Sweden. The

Invitation to presentation of ICA Gruppen’s interim report for the third quarter

ICA Gruppen will publish its interim report for the third quarter on Friday October 23. In conjunction to this, we are pleased to issue this invitation to a live webcast for the press and the financial market.Time:  Friday October 23 at 10.00 CET ICA Gruppen’s CEO Per Strömberg and CFO Sven Lindskog will present the interim report and answer any subsequent questions. The presentation can be viewed at http://www.icagruppen.se/en/investors To attend the telephone conference: SE: +46 8 505 583 52 UK: +44 333 300 9035 A recorded version of the audio cast will be available on

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 73 - 16 OCTOBER 2020 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, Motortramp A/S continuously sells shares pro rata and the market is to be informed accordingly – see the attached file. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451Anne-Louise Dam-Rasmussen, Head of Communications, tel.: +45 3273 0624

Invitation to the presentation of Bonava's interim report for the third quarter 2020

Bonava AB (publ) will publish its interim report for the third quarter 2020 on October 23 at 07:30 CET. Following the publication, Bonava will host a telephone conference and audiocast at 10.00 CET.The report will be presented by Joachim Hallengren, President and CEO and Ann-Sofi Danielsson, CFO. To participate in the telephone conference, dial one of the following numbers: SE:  +46 856 642 651DE:  +49 691 380 34 30UK: +44 333 300 08 04US: +16 319 131 422 Please call in a few minutes before the start time to register your attendance with the pin code: 73694087#    The

Costamare takes maritime training to new heights with Wärtsilä Cloud Simulation solution

Wärtsilä Corporation, Trade press release, 16 October 2020 at 10:00 AM EESTThe technology group Wärtsilä has received yet another order for its advanced Cloud Simulation solution.  The Costamare Maritime Training Services (Costamare MTS) centre in Greece is the latest facility to take advantage of the technology developed by Wärtsilä Voyage, enabling its students to continue their training despite travel and assembly restrictions imposed because of the Covid-19 pandemic. It also allows the training centre to expand its services to

Observe Medical ASA – Signs agreement with the intention to acquire Sylak AB

Observe Medical ASA, October 16, 2020: Observe Medical ASA (the "Company" or "Observe Medical") has signed a non-binding term sheet including an exclusive right to acquire 100% of the shares in Sylak AB (“Sylak”), a Swedish private limited company, for an agreed enterprise value of SEK 6 million (on a cash and debt free basis) from ABIGO Medical AB (“ABIGO Medical”). The contemplated acquisition will significantly strengthen Observe Medical’s commercial organization and corresponding go-to-market execution power in the Nordics. Sylak is a distributor of ICU/anesthesia products in the

Statement by the Board of Directors of Internationella Engelska Skolan in view of Peutinger AB’s mandatory offer

Internationella Engelska Skolan’s independent members of the Board of Directors unanimously recommends the shareholders not to accept the Offeror’s mandatory public offer.Background This statement is made by Internationella Engelska Skolan i Sverige Holdings II AB (publ)’s (“IES” or the “Company”) independent members of the Board of Directors (the “Board”) pursuant to section II.19 of the Nasdaq Stockholm takeover rules (the “Takeover Rules”).[1] On 25 September 2020, Peutinger AB[2] (the "Offeror"), owned by a consortium led by Paradigm Capital Value Fund SICAV, as well as Paradigm

Nomination Committee for Scandic’s AGM 2021 appointed

In accordance with the instruction to the Nomination Committee, Scandic’s Nomination Committee is made up of Scandic’s three largest shareholders as per August 31, 2020 and the Chair of the Board of Directors. Prior to the Annual General Meeting 2021, the Nomination Committee is composed as follows:· Karl Swartling, Stena Sessan AB, Chair of the Nomination Committee  · Dick Bergqvist, AMF Insurance & Funds  · Olof Cato, Formica Capital AB  · Per G. Braathen, Chair of the Board of Directors of Scandic Hotels Group  · Camilla Köhler, Secretary of the Nomination Committee

Evolution enters into agreement with Wynn for the US market

Evolution, leading provider of Live Casino solutions, has entered into a partnership with Wynn Sports Interactive (WSI) for the supply of Live Casino content and services for the US market.The partnership with WSI will see Wynn Sports offer Evolution’s live games initially in New Jersey with additional states to follow. The Evolution live games offered to Wynn Sports players include a wide selection of games streamed live from Evolution’s Atlantic City studio: Roulette, Blackjack, Infinite Blackjack, Baccarat, Three Card Poker, Ultimate Texas Hold’em, and the Dream Catcher money wheel game

Invitation to conference call, October 23 at 13:30 pm CET

Studsvik AB presents its Interim Report for the third quarter 2020 and hereby invites media and analysts to a conference call held in English on Friday, October 23 at 13:30 CET.Studsvik’s Interim Report for the third quarter 2020 will be distributed at approximately 12:00 CET, October 23. As of this time, the report will also be available at www.studsvik.com. The call will be held in English, starting 13:30 CET. Please call at least ten minutes prior to the start of the conference call to avoid delay. Event title is: Studsvik Q3 2020. Conference ID is: 7747679 Description

Neste, Recycling Technologies and Unilever combine expertise to test and validate systems to chemically recycle waste plastics

Neste Corporation, Press Release, 16 October 2020 at 09:05 a.m. (EET) Photo: Waste plastic to Plaxx, Recycling Technologies Recycling Technologies, a specialist plastic recycling technology provider; Neste, the world’s leading provider of renewable diesel, sustainable aviation fuel, and a forerunner in drop-in renewable and circular chemical solutions; and Unilever, the consumer goods manufacturer of leading global brands, will collaborate to further develop and harness chemical recycling to recover and reuse plastic packaging that is currently either incinerated, buried in

BEWi intends to divest real estate in the Netherlands

BEWi ASA, parent company of BEWiSynbra Group AB (publ) and a leading international provider of packaging, components and insulation solutions, has entered into a letter of intent with KMC Properties AS regarding the divestment of certain real estate owned by the company located in the Netherlands for a cash consideration of approximately NOK 300 million. The contemplated transaction will constitute a related party transaction since KMC Properties AS partly is indirectly owned by Bekken Invest AS, which indirectly controls 58.6 per cent of the shares in BEWi ASA through KMC Family AS and

There are no items matching the current filter
There are no more items matching the current filter
Back to top